VanEck Pharmaceutical ETF
PPH
PPH
50 hedge funds and large institutions have $56.5M invested in VanEck Pharmaceutical ETF in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
58% less call options, than puts
Call options by funds: $866K | Put options by funds: $2.07M
Holders
50
Holding in Top 10
–
Calls
$866K
Puts
$2.07M
Top Buyers
| 1 | +$6.78M | |
| 2 | +$3.26M | |
| 3 | +$255K | |
| 4 |
Morgan Stanley
New York
|
+$156K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$94.1K |
Top Sellers
| 1 | -$2.93M | |
| 2 | -$1.84M | |
| 3 | -$1.16M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$865K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$264K |